This invention is directed to oral-intestinal vaccines and their use against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres.

 
Web www.patentalert.com

< Method and composition for administering an NMDA receptor antagonist to a subject

> Method of treating inflammatory disease by inhibition of IL-17 production

> Methods for the treatment of cancer using anti-CD40 antibodies
~ 00552